The Impact and Cost of Scaling up GeneXpert MTB/RIF in South Africa

OBJECTIVE: We estimated the incremental cost and impact on diagnosis and treatment uptake of national rollout of Xpert MTB/RIF technology (Xpert) for the diagnosis of pulmonary TB above the cost of current guidelines for the years 2011 to 2016 in South Africa. METHODS: We parameterised a population-...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Meyer-Rath, Gesine, Schnippel, Kathryn, Long, Lawrence, MacLeod, William, Sanne, Ian, Stevens, Wendy, Pillay, Sagie, Pillay, Yogan, Rosen, Sydney
Format: Artigo
Langue:Inglês
Publié: Public Library of Science 2012
Sujets:
Research Article
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC3365041/
https://ncbi.nlm.nih.gov/pubmed/22693561
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0036966
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires